In a nutshell: Testing <scp>DOAC</scp> levels—when, why and what it means?
Plasma direct oral anticoagulant (DOAC) levels are not routinely required for the majority of patients; however, they may provide valuable information in urgent clinical situations, including perioperative management, life- or limb-threatening bleeding and patients requiring thrombolysis, when measurement mostly aims to determine whether a clinically significant concentration of DOAC is present in plasma. In non-urgent indications, including investigation of DOAC failure and in patients with extremes of body weight or drug-drug interactions, levels may assist clinical decision-making by determining whether the plasma DOAC level is within expected therapeutic ranges. 'In a nut-shell' review, we summarise the current recommendations and limitations regarding testing DOAC levels.
Authors
- Lara N. Roberts (ORCID: https://orcid.org/0000-0003-3871-8491)
- Dawn Swan (ORCID: https://orcid.org/0000-0003-1374-7333)
- Jecko Thachil
Institutions
- King's College London (GB)
- University of Manchester (GB)
- King's College Hospital NHS Foundation Trust (GB)
- Austin Health (AU)
Publication Details
- Journal
- British Journal of Haematology
- Published
- 2026-01-02
- DOI
- https://doi.org/10.1111/bjh.70313
- Primary Topic
- Atrial Fibrillation Management and Outcomes
- Type
- article
- Field-Weighted Citation Impact
- 0.00